Shareholders reject $9bn CoreWeave offer for Core Scientific ⊖
Deal’s collapse could hurt CoreWeave plans to meet growth targets that have driven soaring stock price
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.